Allergoferon

Overdose

Cases of drug overdose have not been identified.

Contraindications

hypersensitivity to the components of the drug,

pregnancy,

breastfeeding period,

children under 18 years of age.

Incompatibilities

Possible combination with the use of systemic antihistamines.

The use of intranasal vasoconstrictor drugs in conjunction with the drug Allergoferon® it is not recommended, because it contributes to additional drying of the nasal mucosa.

If the patient uses the above or other medications (including over-the-counter), consult your doctor before using the drug.

Pharmaceutical form

The gel is white or white with a grayish tinge of color with a faint specific smell.

Undesirable effects

There may be sneezing, itching and a temporary violation of the sense of smell when applying the drug.

If the patient experiences or worsens the side effects listed in the description, or the patient notices any other side effects not listed in the description, you should inform your doctor.

Pharmacy sales terms

Without a prescription.

Special instructions

When applying the product on the eyelids to eliminate the use of cosmetic products.

Before using the drug intranasally, it is necessary to clean the nasal passages.

Influence on the ability to drive vehicles, mechanisms. Loratadine does not have a sedative effect. In some cases, when used simultaneously with systemic antihistamines, a sedative effect may develop. In this case, it is necessary to take into account the likelihood of a decrease in the speed of attention, which may affect the ability to drive vehicles and mechanisms.

Therapeutic indications

Treatment of exacerbations of allergic diseases:

hay fever (seasonal allergic rhinitis, allergic conjunctivitis),

year-round allergic rhinitis, allergic conjunctivitis.

Symptoms of exacerbation of allergic rhinitis: itching in the nose, nasal congestion, sneezing, discharge of watery secretions from the nose.

Symptoms of exacerbation of allergic conjunctivitis: itching of the eyelids, swelling of the eyelids, lacrimation, redness of the mucous membrane of the eyes.

Pharmacotherapeutic group

  • Combined anti-allergic agent (H1- histamine receptor blocker cytokine) [H1- antihistamines in combinations]

Pharmacodynamic properties

The drug Allergoferon®, gel for topical and external use, has antihistamine, antiallergic, antipruritic, antiexudative, anti-inflammatory, immunomodulatory, antiviral effect.

Interferon alpha-2b it has an immunomodulatory and antiviral effect.

Loratadine - blocker H1- histamine receptors. It has a local anti-allergic effect, reduces swelling of the mucous membranes and soft tissues, reduces exudation, burning and itching, facilitates the patency of the nasal passages, facilitates nasal breathing. It has an anti-inflammatory effect.

Pharmacokinetic properties

The drug has a local effect. The concentration of active substances reached in the blood is significantly lower than the detection limit (the limit for determining interferon alpha-2b is 1-2 IU / ml) and has no clinical significance.

Special precautions for storage

At a temperature of 2-8 °C.

Keep out of reach of children.

The shelf life of the drug Allegation®2 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Gel for topical and external use 1 g
active ingredients:  
interferon alpha-2b human recombinant at least 5000 ME
loratadine 0.01 g
excipients: sorbic acid-2 mg, disodium edetate dihydrate-1 mg, carbomer-10 mg, trollamine-10 mg, macrogol 4000-150 mg, macrogol 400-300 mg, purified water-up to 1000 mg  
Release form

Gel for topical and external use. 5 or 10 g each in an aluminum tube with bouchon. 1 tube in a pack of cardboard.

Fertility, pregnancy and lactation

It is contraindicated during pregnancy and during breastfeeding.

Nosological classification (ICD-10)

  • H10. 1 Acute atopic conjunctivitis
  • J30 Vasomotor and allergic rhinitis
  • J30. 1 Allergic rhinitis caused by plant pollen
  • J30. 2 Other seasonal allergic rhinitis

Dosage (Posology) and method of administration

Externally.

Allergic rhinitis. The drug is used by applying 1 cm of gel to the mucous membrane of each nasal passage 4 times a day for 5-7 days. After applying the gel, massage the wings of the nose with your fingers to evenly distribute the drug on the mucous membrane of the nasal passages.

Allergic conjunctivitis. The drug is used by applying 1 cm of gel to the skin of the upper and lower eyelids 4 times a day for 5-7 days.

The drug is discontinued after the disappearance of clinical symptoms.

After consultation with a doctor, if further use of the drug is necessary, the maximum continuous course of use should not exceed 6 weeks.

In the phase of remission of the disease (absence of symptoms of the disease), the drug is not used.

If within 7 days of using the drug, the therapeutic effect was absent (the symptoms did not disappear or did not weaken), as well as if there were adverse events, it is necessary to stop using the drug and consult a doctor.